Published in AIDS Weekly, March 18th, 1996
Ritonavir received full approval for use alone or in combination with nucleoside analogue medications, such as AZT, in people with advanced HIV disease. Ritonavir also received accelerated approval for less advanced HIV disease. FDA approved the drug about two months after receiving its application for its marketing.
"Even as we celebrate this milestone, we must recommit ourselves to President Clinton's goal of finding a cure," said HHS Secretary Donna E. Shalala. "We must also face the new challenge of providing life-prolonging medications to all...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.